The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 28, 2015

Filed:

Dec. 17, 2008
Applicants:

Tetsuro Kikuchi, Osaka, JP;

Kenji Maeda, Osaka, JP;

Geoffrey Guy, Glanvilles Wootton, GB;

Philip Robson, Wiltshire, GB;

Colin Stott, Wiltshire, GB;

Inventors:

Tetsuro Kikuchi, Osaka, JP;

Kenji Maeda, Osaka, JP;

Geoffrey Guy, Glanvilles Wootton, GB;

Philip Robson, Wiltshire, GB;

Colin Stott, Wiltshire, GB;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 36/00 (2006.01); A61K 45/06 (2006.01); A61K 31/05 (2006.01); A61K 31/35 (2006.01); A61K 31/352 (2006.01); A61K 36/185 (2006.01);
U.S. Cl.
CPC ...
A61K 45/06 (2013.01); A61K 31/05 (2013.01); A61K 31/35 (2013.01); A61K 31/352 (2013.01); A61K 36/185 (2013.01);
Abstract

The present invention relates to the use of one or more cannabinoids in combination with one or more anti-psychotic medicaments for use in the prevention or treatment of psychosis and psychotic disorders. Preferably the one or more cannabinoids are taken from the group: cannabidiol (CBD); cannabidiolic acid (CBDA); tetrahydrocannbidivarin (THCV); tetrahydrocannbidivarinin acid (THCVA); cannabichromene (CBC); cannabichromenic acid (CBCA); cannabigerol (CBG) and cannabigerolic acid (CBGA). Preferably the anti-psychotic medication is an atypical anti-psychotic medication.


Find Patent Forward Citations

Loading…